| ADCY1 |
adenylate cyclase 1 (brain) |
| ADCY2 |
adenylate cyclase 2 (brain) |
| ADCY3 |
adenylate cyclase 3 |
| ADCY5 |
adenylate cyclase 5 |
| ADCY6 |
adenylate cyclase 6 |
| ADCY7 |
adenylate cyclase 7 |
| ADCY8 |
adenylate cyclase 8 (brain) |
| ADCY9 |
adenylate cyclase 9 |
| AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
| AKT2 |
v-akt murine thymoma viral oncogene homolog 2 |
| SLC25A4 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
| SLC25A5 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 |
| SLC25A6 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 |
| APC |
adenomatous polyposis coli |
| XIAP |
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase |
| ATF1 |
activating transcription factor 1 |
| ATF3 |
activating transcription factor 3 |
| ATF4 |
activating transcription factor 4 |
| ATM |
ATM serine/threonine kinase |
| ATR |
ATR serine/threonine kinase |
| BAX |
BCL2-associated X protein |
| CCND1 |
cyclin D1 |
| BCL2L1 |
BCL2-like 1 |
| BUB1B |
BUB1 mitotic checkpoint serine/threonine kinase B |
| TSPO |
translocator protein (18kDa) |
| CALR |
calreticulin |
| CANX |
calnexin |
| CCND2 |
cyclin D2 |
| CCND3 |
cyclin D3 |
| CD3D |
CD3d molecule, delta (CD3-TCR complex) |
| CD3E |
CD3e molecule, epsilon (CD3-TCR complex) |
| CD3G |
CD3g molecule, gamma (CD3-TCR complex) |
| CD40 |
CD40 molecule, TNF receptor superfamily member 5 |
| CDC20 |
cell division cycle 20 |
| CDC27 |
cell division cycle 27 |
| CDK4 |
cyclin-dependent kinase 4 |
| CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
| CDKN2A |
cyclin-dependent kinase inhibitor 2A |
| CDKN2B |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
| CDKN2C |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
| CHEK1 |
checkpoint kinase 1 |
| CHUK |
conserved helix-loop-helix ubiquitous kinase |
| CREB1 |
cAMP responsive element binding protein 1 |
| ATF2 |
activating transcription factor 2 |
| CREBBP |
CREB binding protein |
| CREM |
cAMP responsive element modulator |
| CSF2 |
colony stimulating factor 2 (granulocyte-macrophage) |
| CTNNB1 |
catenin (cadherin-associated protein), beta 1, 88kDa |
| DLG1 |
discs, large homolog 1 (Drosophila) |
| DVL1 |
dishevelled segment polarity protein 1 |
| DVL2 |
dishevelled segment polarity protein 2 |
| DVL3 |
dishevelled segment polarity protein 3 |
| E2F1 |
E2F transcription factor 1 |
| E2F2 |
E2F transcription factor 2 |
| E2F3 |
E2F transcription factor 3 |
| EGR1 |
early growth response 1 |
| EGR2 |
early growth response 2 |
| ELK1 |
ELK1, member of ETS oncogene family |
| ELK4 |
ELK4, ETS-domain protein (SRF accessory protein 1) |
| EP300 |
E1A binding protein p300 |
| ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
| ETS2 |
v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
| FDPS |
farnesyl diphosphate synthase |
| FOS |
FBJ murine osteosarcoma viral oncogene homolog |
| FZD2 |
frizzled class receptor 2 |
| KAT2A |
K(lysine) acetyltransferase 2A |
| GPS2 |
G protein pathway suppressor 2 |
| GSK3B |
glycogen synthase kinase 3 beta |
| HLA-A |
major histocompatibility complex, class I, A |
| HLA-B |
major histocompatibility complex, class I, B |
| HLA-C |
major histocompatibility complex, class I, C |
| HLA-DMA |
major histocompatibility complex, class II, DM alpha |
| HLA-DMB |
major histocompatibility complex, class II, DM beta |
| HLA-DOA |
major histocompatibility complex, class II, DO alpha |
| HLA-DOB |
major histocompatibility complex, class II, DO beta |
| HLA-DPA1 |
major histocompatibility complex, class II, DP alpha 1 |
| HLA-DPB1 |
major histocompatibility complex, class II, DP beta 1 |
| HLA-DQA1 |
major histocompatibility complex, class II, DQ alpha 1 |
| HLA-DQA2 |
major histocompatibility complex, class II, DQ alpha 2 |
| HLA-DQB1 |
major histocompatibility complex, class II, DQ beta 1 |
| HLA-DRA |
major histocompatibility complex, class II, DR alpha |
| HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1 |
| HLA-DRB3 |
major histocompatibility complex, class II, DR beta 3 |
| HLA-DRB4 |
major histocompatibility complex, class II, DR beta 4 |
| HLA-DRB5 |
major histocompatibility complex, class II, DR beta 5 |
| HLA-E |
major histocompatibility complex, class I, E |
| HLA-F |
major histocompatibility complex, class I, F |
| HLA-G |
major histocompatibility complex, class I, G |
| HRAS |
Harvey rat sarcoma viral oncogene homolog |
| ICAM1 |
intercellular adhesion molecule 1 |
| IKBKB |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
| IL1R1 |
interleukin 1 receptor, type I |
| IL2 |
interleukin 2 |
| IL2RA |
interleukin 2 receptor, alpha |
| IL2RB |
interleukin 2 receptor, beta |
| IL2RG |
interleukin 2 receptor, gamma |
| IL6 |
interleukin 6 |
| IL15 |
interleukin 15 |
| IL15RA |
interleukin 15 receptor, alpha |
| ITGAL |
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
